JP2000508673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000508673A5 JP2000508673A5 JP1997537711A JP53771197A JP2000508673A5 JP 2000508673 A5 JP2000508673 A5 JP 2000508673A5 JP 1997537711 A JP1997537711 A JP 1997537711A JP 53771197 A JP53771197 A JP 53771197A JP 2000508673 A5 JP2000508673 A5 JP 2000508673A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19615812.5 | 1996-04-20 | ||
| DE19615812A DE19615812A1 (de) | 1996-04-20 | 1996-04-20 | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
| PCT/EP1997/001940 WO1997039755A1 (de) | 1996-04-20 | 1997-04-21 | Orale pharmazeutische zubereitung enthaltend ibandronat |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008178294A Division JP5557989B2 (ja) | 1996-04-20 | 2008-07-08 | イバンドロネートを含む経口薬理製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000508673A JP2000508673A (ja) | 2000-07-11 |
| JP2000508673A5 true JP2000508673A5 (enExample) | 2005-01-13 |
| JP5037746B2 JP5037746B2 (ja) | 2012-10-03 |
Family
ID=7791961
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53771197A Expired - Lifetime JP5037746B2 (ja) | 1996-04-20 | 1997-04-21 | イバンドロネートを含む経口薬理製剤 |
| JP2008178294A Expired - Lifetime JP5557989B2 (ja) | 1996-04-20 | 2008-07-08 | イバンドロネートを含む経口薬理製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008178294A Expired - Lifetime JP5557989B2 (ja) | 1996-04-20 | 2008-07-08 | イバンドロネートを含む経口薬理製剤 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US6143326A (enExample) |
| EP (2) | EP0936913B2 (enExample) |
| JP (2) | JP5037746B2 (enExample) |
| CN (1) | CN101152160A (enExample) |
| AR (2) | AR006652A1 (enExample) |
| AT (1) | ATE404207T1 (enExample) |
| AU (1) | AU722516B2 (enExample) |
| BR (1) | BR9708785A (enExample) |
| CA (1) | CA2251886C (enExample) |
| CO (1) | CO4820394A1 (enExample) |
| CZ (1) | CZ297341B6 (enExample) |
| DE (2) | DE19615812A1 (enExample) |
| DK (1) | DK0936913T4 (enExample) |
| ES (1) | ES2313735T5 (enExample) |
| HU (1) | HU228389B1 (enExample) |
| IL (2) | IL126655A (enExample) |
| NO (1) | NO319162B1 (enExample) |
| NZ (1) | NZ332314A (enExample) |
| PA (1) | PA8427301A1 (enExample) |
| PL (2) | PL191910B1 (enExample) |
| PT (1) | PT936913E (enExample) |
| RU (1) | RU2193881C2 (enExample) |
| SI (1) | SI0936913T2 (enExample) |
| TR (1) | TR199802108T2 (enExample) |
| WO (1) | WO1997039755A1 (enExample) |
| ZA (1) | ZA973331B (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19615812A1 (de) | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
| SK284690B6 (sk) * | 1997-06-11 | 2005-09-08 | The Procter And Gamble Company | Ústna dávkovacia forma na zvýšenie ochrany horného tráviaceho traktu |
| EP0998932A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| AR024462A1 (es) | 1999-07-01 | 2002-10-02 | Merck & Co Inc | Tabletas farmaceuticas |
| US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| US6881420B2 (en) * | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
| US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| KR100863146B1 (ko) * | 2000-07-17 | 2008-10-14 | 아스텔라스세이야쿠 가부시키가이샤 | 경구 흡수 개선 의약 조성물 |
| AR034199A1 (es) * | 2001-02-01 | 2004-02-04 | Riderway Corp | Composicion farmacologica liquida para el tratamiento de enfermedades oseas y procedimientos para su elaboracion |
| JP2002332235A (ja) * | 2001-02-01 | 2002-11-22 | Riderway Corp | 骨疾患治療用液体医薬組成物 |
| ATE330616T1 (de) * | 2001-05-02 | 2006-07-15 | Novartis Pharma Gmbh | Verabreichung von bisphosphonaten durch inhalation zur behandlung von knochenresorption und osteoporosis |
| PL362378A1 (en) * | 2001-12-19 | 2004-10-18 | Astrazeneca Ab | New film coating |
| IL162053A0 (en) * | 2001-12-21 | 2005-11-20 | Procter & Gamble | Method for the treatment of bone disorders |
| ATE536173T1 (de) | 2002-02-21 | 2011-12-15 | Biovail Lab Int Srl | Formulierungen mit modifizierter freisetzung von mindestens einer form von tramadol |
| EP2851105A1 (en) * | 2002-05-10 | 2015-03-25 | F. Hoffmann-La Roche AG | Bisphosphonic acids for treatment and prevention of osteoporosis |
| GB0229258D0 (en) * | 2002-12-16 | 2003-01-22 | Boots Healthcare Int Ltd | Medicinal compositions |
| WO2004056373A1 (en) | 2002-12-20 | 2004-07-08 | F. Hoffmann-La Roche Ag | High dose ibandronate formulation |
| TR200300510A2 (tr) * | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
| RU2262923C2 (ru) * | 2003-12-25 | 2005-10-27 | Государственное образовательное учреждение высшего профессионального образования Курский государственный медицинский университет Министерства здравоохранения Российской Федерации | Иммобилизованная форма доксорубицина |
| GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
| US7645460B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of risedronate |
| US20080287400A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US7645459B2 (en) | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
| US20080286359A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| WO2008128056A1 (en) * | 2004-10-08 | 2008-10-23 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps |
| US7358361B2 (en) * | 2004-10-08 | 2008-04-15 | The Board Of Trustees Of The University Of Illinois | Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
| US20070191315A1 (en) * | 2006-02-16 | 2007-08-16 | Bengt Bergstrom | Method for administering ibandronate |
| AU2007226964B2 (en) * | 2006-03-17 | 2012-03-22 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods |
| JPWO2008013084A1 (ja) * | 2006-07-25 | 2009-12-17 | 興和株式会社 | 糖衣製剤およびその製造方法 |
| GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
| US20080139514A1 (en) * | 2006-11-29 | 2008-06-12 | Subhash Pandurang Gore | Diphosphonic acid pharmaceutical compositions |
| CA2570949A1 (en) * | 2006-12-12 | 2008-06-12 | Apotex Pharmachem Inc. | Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| WO2009075601A1 (fr) * | 2007-12-12 | 2009-06-18 | Alexander Valerievich Melnik | Moyen d'indication d'une éventuelle prédisposition de chats à une maladie (variantes) et procédé de détermination de troubles de la santé chez les chats |
| EP2210596A1 (en) * | 2009-01-22 | 2010-07-28 | Laboratorios Liconsa, S.A. | Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof |
| WO2012029820A1 (ja) * | 2010-08-31 | 2012-03-08 | 東レ株式会社 | 医薬固形製剤用のコーティング剤、医薬用フィルム製剤及び被覆医薬固形製剤 |
| EP2720681B1 (en) | 2011-06-17 | 2016-11-23 | Evonik Röhm GmbH | Coating composition suitable for pharmaceutical or nutraceutical dosage forms |
| RU2485957C1 (ru) * | 2012-03-16 | 2013-06-27 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия последипломного образования" Министерства здравоохранения Российской Федерации (ГБОУ ДПО РМАПО Минздрава России) | Средство для лечения низкообменного варианта заболевания скелета у больных с хронической почечной недостаточностью |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE965825C (de) | 1949-10-30 | 1957-06-19 | Walter Kloepfer Dipl Ing Dr In | Zur Antennenebene senkrecht polarisierter Strahler |
| US4820698A (en) * | 1985-11-04 | 1989-04-11 | The Procter & Gamble Company | Antimicrobial agents and process for their manufacture |
| DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| US5098717A (en) * | 1987-12-09 | 1992-03-24 | Thames Pharmacal Co., Inc. | Method of treatment for pruritus |
| PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
| EP0550385A1 (de) * | 1991-12-19 | 1993-07-07 | Ciba-Geigy Ag | Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten |
| TW237386B (enExample) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
| US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
| RU2134103C1 (ru) * | 1993-05-15 | 1999-08-10 | Берингер Маннхайм ГмбХ | Таблетка с улучшенной биодоступностью биологически активного вещества и вещество, повышающее биодоступность |
| US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
| TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
| DE19615812A1 (de) | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
| US5803321A (en) * | 1996-11-12 | 1998-09-08 | Randy Hangers, Lll | Hanger with ganging element |
| US20060045865A1 (en) * | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
-
1996
- 1996-04-20 DE DE19615812A patent/DE19615812A1/de not_active Withdrawn
-
1997
- 1997-04-08 CO CO97017783A patent/CO4820394A1/es unknown
- 1997-04-15 AR ARP970101504A patent/AR006652A1/es active IP Right Grant
- 1997-04-17 PA PA19978427301A patent/PA8427301A1/es unknown
- 1997-04-18 ZA ZA973331A patent/ZA973331B/xx unknown
- 1997-04-21 AT AT97918146T patent/ATE404207T1/de active
- 1997-04-21 IL IL12665597A patent/IL126655A/en not_active IP Right Cessation
- 1997-04-21 CZ CZ0336498A patent/CZ297341B6/cs not_active IP Right Cessation
- 1997-04-21 BR BR9708785A patent/BR9708785A/pt not_active Application Discontinuation
- 1997-04-21 EP EP97918146A patent/EP0936913B2/de not_active Expired - Lifetime
- 1997-04-21 NZ NZ332314A patent/NZ332314A/xx not_active IP Right Cessation
- 1997-04-21 SI SI9730781T patent/SI0936913T2/sl unknown
- 1997-04-21 WO PCT/EP1997/001940 patent/WO1997039755A1/de not_active Ceased
- 1997-04-21 PL PL369034A patent/PL191910B1/pl unknown
- 1997-04-21 JP JP53771197A patent/JP5037746B2/ja not_active Expired - Lifetime
- 1997-04-21 RU RU98120909/14A patent/RU2193881C2/ru active
- 1997-04-21 CA CA002251886A patent/CA2251886C/en not_active Expired - Lifetime
- 1997-04-21 PL PL329347A patent/PL191363B1/pl unknown
- 1997-04-21 DK DK97918146.8T patent/DK0936913T4/da active
- 1997-04-21 EP EP06001911.4A patent/EP1658852B1/de not_active Revoked
- 1997-04-21 US US09/147,149 patent/US6143326A/en not_active Expired - Lifetime
- 1997-04-21 PT PT97918146T patent/PT936913E/pt unknown
- 1997-04-21 AU AU26382/97A patent/AU722516B2/en not_active Expired
- 1997-04-21 HU HU9903407A patent/HU228389B1/hu unknown
- 1997-04-21 DE DE59712959T patent/DE59712959D1/de not_active Expired - Lifetime
- 1997-04-21 ES ES97918146T patent/ES2313735T5/es not_active Expired - Lifetime
- 1997-04-21 IL IL16393097A patent/IL163930A0/xx unknown
- 1997-04-21 CN CNA2007101536726A patent/CN101152160A/zh active Pending
- 1997-04-21 TR TR1998/02108T patent/TR199802108T2/xx unknown
-
1998
- 1998-10-19 NO NO19984881A patent/NO319162B1/no not_active IP Right Cessation
-
2003
- 2003-09-12 US US10/660,785 patent/US20050089573A1/en not_active Abandoned
-
2006
- 2006-04-24 AR ARP060101621A patent/AR054350A2/es unknown
-
2008
- 2008-07-08 JP JP2008178294A patent/JP5557989B2/ja not_active Expired - Lifetime